Demographic and Clinical Characteristics of Household Contacts Whose Nasopharyngeal Specimens Tested Positive or Negative for Severe Acute Respiratory Syndrome Coronavirus 2 by Polymerase Chain Reactiona
| Characteristic . | SARS-CoV-2 rRT-PCR Positive (n = 47) . | SARS-CoV-2 rRT-PCR Negative (n = 148) . |
|---|---|---|
| Sex | ||
| Male | 18 (38) | 78 (53) |
| Female | 29 (62) | 70 (47) |
| Age category, y | ||
| <18 | 14 (30) | 55 (37) |
| 18–49 | 20 (43) | 69 (47) |
| 50–64 | 10 (21) | 19 (13) |
| ≥65 | 3 (6) | 5 (3) |
| Race | ||
| White | 35 (74) | 109 (74) |
| Black/African American | 4 (9) | 22 (15) |
| Asian | 4 (9) | 10 (7) |
| American Indian/Alaska Native | 1 (2) | 3 (2) |
| Native Hawaiian/other Pacific Islander | 0 (0) | 2 (1) |
| Multiracial | 3 (6) | 1 (1) |
| Ethnicity | ||
| Non-Hispanic | 42 (89) | 121 (82) |
| Hispanic | 5 (11) | 27 (18) |
| State of residence | ||
| Utah | 31 (66) | 100 (68) |
| Wisconsin | 16 (34) | 48 (32) |
| Any underlying medical conditionb | 24 (51) | 39 (26) |
| Any chronic lung disease | 9 (19) | 26 (18) |
| Any cardiovascular disease | 6 (13) | 14 (9) |
| Diabetes mellitus | 4 (9) | 2 (1) |
| Any chronic kidney disease | 1 (2) | 1 (1) |
| Any chronic liver disease | 1 (2) | 1 (1) |
| Any immunocompromising condition | 2 (4) | 1 (1) |
| Other | 6 (13) | 4 (3) |
| Characteristic . | SARS-CoV-2 rRT-PCR Positive (n = 47) . | SARS-CoV-2 rRT-PCR Negative (n = 148) . |
|---|---|---|
| Sex | ||
| Male | 18 (38) | 78 (53) |
| Female | 29 (62) | 70 (47) |
| Age category, y | ||
| <18 | 14 (30) | 55 (37) |
| 18–49 | 20 (43) | 69 (47) |
| 50–64 | 10 (21) | 19 (13) |
| ≥65 | 3 (6) | 5 (3) |
| Race | ||
| White | 35 (74) | 109 (74) |
| Black/African American | 4 (9) | 22 (15) |
| Asian | 4 (9) | 10 (7) |
| American Indian/Alaska Native | 1 (2) | 3 (2) |
| Native Hawaiian/other Pacific Islander | 0 (0) | 2 (1) |
| Multiracial | 3 (6) | 1 (1) |
| Ethnicity | ||
| Non-Hispanic | 42 (89) | 121 (82) |
| Hispanic | 5 (11) | 27 (18) |
| State of residence | ||
| Utah | 31 (66) | 100 (68) |
| Wisconsin | 16 (34) | 48 (32) |
| Any underlying medical conditionb | 24 (51) | 39 (26) |
| Any chronic lung disease | 9 (19) | 26 (18) |
| Any cardiovascular disease | 6 (13) | 14 (9) |
| Diabetes mellitus | 4 (9) | 2 (1) |
| Any chronic kidney disease | 1 (2) | 1 (1) |
| Any chronic liver disease | 1 (2) | 1 (1) |
| Any immunocompromising condition | 2 (4) | 1 (1) |
| Other | 6 (13) | 4 (3) |
Data are presented as no. (%).
Abbreviations: rRT-PCR, real-time reverse-transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
aData collection in Wisconsin and Utah household contact cohort, 22 March–22 April 2020.
bAny chronic lung disease: asthma, chronic obstructive pulmonary disease, or other chronic lung disease; any cardiovascular disease: hypertension, coronary artery disease/myocardial infarction, or other cardiovascular disease; any chronic kidney disease: end-stage renal disease, renal insufficiency, or other kidney disease; any liver disorder: nonalcoholic fatty liver disease or other chronic liver condition; any immunocompromising condition: human immunodeficiency virus, cancer, or other immunosuppressive condition; and any other chronic condition: anemia, psoriasis, thyroid disorder.
Demographic and Clinical Characteristics of Household Contacts Whose Nasopharyngeal Specimens Tested Positive or Negative for Severe Acute Respiratory Syndrome Coronavirus 2 by Polymerase Chain Reactiona
| Characteristic . | SARS-CoV-2 rRT-PCR Positive (n = 47) . | SARS-CoV-2 rRT-PCR Negative (n = 148) . |
|---|---|---|
| Sex | ||
| Male | 18 (38) | 78 (53) |
| Female | 29 (62) | 70 (47) |
| Age category, y | ||
| <18 | 14 (30) | 55 (37) |
| 18–49 | 20 (43) | 69 (47) |
| 50–64 | 10 (21) | 19 (13) |
| ≥65 | 3 (6) | 5 (3) |
| Race | ||
| White | 35 (74) | 109 (74) |
| Black/African American | 4 (9) | 22 (15) |
| Asian | 4 (9) | 10 (7) |
| American Indian/Alaska Native | 1 (2) | 3 (2) |
| Native Hawaiian/other Pacific Islander | 0 (0) | 2 (1) |
| Multiracial | 3 (6) | 1 (1) |
| Ethnicity | ||
| Non-Hispanic | 42 (89) | 121 (82) |
| Hispanic | 5 (11) | 27 (18) |
| State of residence | ||
| Utah | 31 (66) | 100 (68) |
| Wisconsin | 16 (34) | 48 (32) |
| Any underlying medical conditionb | 24 (51) | 39 (26) |
| Any chronic lung disease | 9 (19) | 26 (18) |
| Any cardiovascular disease | 6 (13) | 14 (9) |
| Diabetes mellitus | 4 (9) | 2 (1) |
| Any chronic kidney disease | 1 (2) | 1 (1) |
| Any chronic liver disease | 1 (2) | 1 (1) |
| Any immunocompromising condition | 2 (4) | 1 (1) |
| Other | 6 (13) | 4 (3) |
| Characteristic . | SARS-CoV-2 rRT-PCR Positive (n = 47) . | SARS-CoV-2 rRT-PCR Negative (n = 148) . |
|---|---|---|
| Sex | ||
| Male | 18 (38) | 78 (53) |
| Female | 29 (62) | 70 (47) |
| Age category, y | ||
| <18 | 14 (30) | 55 (37) |
| 18–49 | 20 (43) | 69 (47) |
| 50–64 | 10 (21) | 19 (13) |
| ≥65 | 3 (6) | 5 (3) |
| Race | ||
| White | 35 (74) | 109 (74) |
| Black/African American | 4 (9) | 22 (15) |
| Asian | 4 (9) | 10 (7) |
| American Indian/Alaska Native | 1 (2) | 3 (2) |
| Native Hawaiian/other Pacific Islander | 0 (0) | 2 (1) |
| Multiracial | 3 (6) | 1 (1) |
| Ethnicity | ||
| Non-Hispanic | 42 (89) | 121 (82) |
| Hispanic | 5 (11) | 27 (18) |
| State of residence | ||
| Utah | 31 (66) | 100 (68) |
| Wisconsin | 16 (34) | 48 (32) |
| Any underlying medical conditionb | 24 (51) | 39 (26) |
| Any chronic lung disease | 9 (19) | 26 (18) |
| Any cardiovascular disease | 6 (13) | 14 (9) |
| Diabetes mellitus | 4 (9) | 2 (1) |
| Any chronic kidney disease | 1 (2) | 1 (1) |
| Any chronic liver disease | 1 (2) | 1 (1) |
| Any immunocompromising condition | 2 (4) | 1 (1) |
| Other | 6 (13) | 4 (3) |
Data are presented as no. (%).
Abbreviations: rRT-PCR, real-time reverse-transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
aData collection in Wisconsin and Utah household contact cohort, 22 March–22 April 2020.
bAny chronic lung disease: asthma, chronic obstructive pulmonary disease, or other chronic lung disease; any cardiovascular disease: hypertension, coronary artery disease/myocardial infarction, or other cardiovascular disease; any chronic kidney disease: end-stage renal disease, renal insufficiency, or other kidney disease; any liver disorder: nonalcoholic fatty liver disease or other chronic liver condition; any immunocompromising condition: human immunodeficiency virus, cancer, or other immunosuppressive condition; and any other chronic condition: anemia, psoriasis, thyroid disorder.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
